HCPCS Level II code A9292 represents a prescription digital visual therapy application that is software-only and FDA cleared, billed per course of treatment. As digital therapeutics expand across clinical specialties, this code standardizes reporting for a non-device, software-based vision therapy delivered over a defined treatment course. Nationally, adoption of software-based prescriptions affects coverage policies, prior authorization practices, and alignment with telehealth and digital health frameworks.

Key payers included in this analysis are Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare. Readers will find an overview of what the code signifies, common billing considerations, and the payer landscape. The publication outlines benchmarks and typical sites of service, summarizes clinical context for prescription digital visual therapy, and highlights policy topics payers and providers are likely to address when integrating FDA-cleared therapeutic software into care pathways.

This resource is intended for billing managers, payers, clinicians, and health policy stakeholders seeking concise, national-level context about HCPCS Level II code A9292, how it is used to report software-only visual therapy per course of treatment, and the policy and operational issues relevant to its uptake.